NATIENS: Optimal Management and Mechanisms of SJS/TEN

Clinical trial NCT02987257 · COMPLETED

Trial details

NCT number: NCT02987257
Sponsor: Vanderbilt University Medical Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Stevens-Johnson Syndrome Toxic Epidermal Necrolyses

Start date: 2023-03-21
Primary completion: 2025-10-31
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.